70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFátima Cardoso, Martine Piccart, Laura J. van’t Veer et al.|New England Journal of Medicine|2016Cited by 2k
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal WomenRowan T. Chlebowski, for the WHI Investigators, Judith K. Ockene et al.|JAMA|2010Cited by 565
Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal WomenRowan T. Chlebowski, Garnet L. Anderson, Lewis H. Kuller et al.|New England Journal of Medicine|2009Cited by 468
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Emiel J. Rutgers, Laura van ‘t Veer et al.|The Lancet Oncology|2021Cited by 355
Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy for Gallbladder CancerSamuel J. Wang, Peter M. Ravdin, Clifton D. Fuller et al.|Journal of Clinical Oncology|2008Cited by 146